Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Degenerative Disc Disease Treatment Market

Degenerative Disc Disease Treatment Market Trends

Report ID: GMI5787
Published Date: May 2023
Report Format: PDF

Download Free Sample

Degenerative Disc Disease Treatment Market Trends

Increasing rate of geriatric population is one of the major factors propelling the market demand. Rising prevalence of bone degenerative disorders such as osteoporosis and rheumatoid arthritis in the geriatric population is expected to boost the demand of degenerative disc disease treatment. Furthermore, geriatric population is more susceptible to the bone degenerative diseases such as spinal stenosis, osteophyte formation, osteomyelitis, degenerative disc herniation among others owing to immunocompromised nature of aging and increasing number of chronic comorbidities.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global Market for degenerative disc disease treatment was USD 24 billion in 2022 and will observe a 7.2% CAGR between 2023 to 2032.

Degenerative disc disease treatment devices market share was over 51% in 2022 and will witness robust growth by 2032 due to the use of specialized devices in different areas of the spine that offers various benefits for managing DDD effectively.

North America degenerative disc disease treatment market accounted for over 57% market share in 2022 due to the increasing prevalence of DDD, coupled with advancements in medical technology and a growing geriatric population.

Pfizer Inc, Medtronic plc, Novartis AG, and B. Braun Melsungen AG.